TY - JOUR AU - Klempfner, Robert AU - Leor, Jonathan AU - Tenenbaum, Alexander AU - Fisman, Enrique Z. AU - Goldenberg, Ilan PY - 2012 DA - 2012/06/06 TI - Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease JO - Cardiovascular Diabetology SP - 60 VL - 11 IS - 1 AB - Diabetic patients present with an accelerated atherosclerotic process and an increased risk for future cardiovascular events. In addition to the risk imposed by the disease itself, pharmacological treatment adds also a sizable risk, especially if certain classes of antidiabetic drugs are employed. Animal evidence indicates that dipeptidyl peptidase-4 inhibitors have anti-atherosclerotic effects, yet clinical data are scarcely available. SN - 1475-2840 UR - https://doi.org/10.1186/1475-2840-11-60 DO - 10.1186/1475-2840-11-60 ID - Klempfner2012 ER -